close

Blogs > Patent Law Blog

Remarks Delivered to The Knowledge Groups Webinar on “Patent Protection for Pharma and Biotechnology in 2018”

On January 26, I was a panelist for The Knowledge Group Webinar on “Patent Protection for Pharma and Biotechnology in 2018.” I discussed the Evolving Role of Secondary Considerations in Formulation Obviousness and the Use of Post-Priority-Date Evidence to Show Lack of Written Description.

Click here to read my remarks and view my PowerPoint slides.

If you have any questions about this or other patent issues, please contact me at KGBriscoe@nmmlaw.com.